Cite
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
MLA
Solomon, S. D., et al. “Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.” New England Journal of Medicine, vol. 381, no. 17, Oct. 2019, pp. 1609–20. EBSCOhost, https://doi.org/10.1056/NEJMoa1908655.
APA
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., van Veldhuisen, D. J., Zannad, F., Zile, M. R., Desai, A. S., Claggett, B., Jhund, P. S., Boytsov, S. A., & Comin-Colet, J. (2019). Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine, 381(17), 1609–1620. https://doi.org/10.1056/NEJMoa1908655
Chicago
Solomon, S. D., J. J. V. McMurray, I. S. Anand, J. Ge, C. S. P. Lam, A. P. Maggioni, F. Martinez, et al. 2019. “Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.” New England Journal of Medicine 381 (17): 1609–20. doi:10.1056/NEJMoa1908655.